| 2-12 Months of Age | 13-36 Months of Age | Significance |
---|---|---|---|
N | 107 | 70 | Â |
Gender, male: female | 57: 50 | 19: 51 | P < 0.001 |
Inpatients/outpatients | 50/57 | 18/52 | P < 0.001 |
Escherichia coli Resistance, N (%) | Â | Â | Â |
   Ampicillin significant | 56 (52%) | 35 (50%) | Not |
   Coamoxyclav significant | 6 (6%) | 9 (13%) | Not |
   Cotrimoxazole significant | 16 (15%) | 15 (21%) | Not |